Display Settings:

Format

Send to:

Choose Destination
    Antiviral Res. 2006 Sep;71(2-3):117-21. Epub 2006 Mar 30.

    Antiviral drug resistance.

    Source

    University of California San Diego, Department of Pathology, 9500 Gilman Drive, La Jolla, CA 92093-0679, United States. drichman@ucsd.edu

    Abstract

    Almost 30 years ago it was proposed that the selection for antiviral drug resistance should be used as an indicator of antiviral drug activity. In addition to discriminating between cellular toxicity and specific activity directed against a viral target, drug resistant mutants have been used to confirm the mechanism of action of antiviral drugs, to discover the functions of several viral proteins and to provide insights into viral evolution and fitness. Drug resistance has also become a standard component of both the preclinical and clinical drug development process. For HIV and increasingly for other viruses drug resistance testing has become standard-of-care in clinical practice. A few selected examples are provided to illustrate each of these points.

    PMID:
    16621040
    [PubMed - indexed for MEDLINE]

      Supplemental Content

      Icon for Elsevier Science

      Save items

      loading

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk